Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China flag China · Delayed Price · Currency is CNY
3.070
+0.060 (1.99%)
Jun 12, 2026, 3:04 PM CST

SHE:300026 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,5581,5021,3061,5741,2061,316
Cash & Short-Term Investments
1,5581,5021,3061,5741,2061,316
Cash Growth
31.24%15.00%-17.00%30.46%-8.34%16.89%
Accounts Receivable
2,5872,5722,8252,8923,5463,694
Other Receivables
29.433.6138.3450.0949.9459.23
Receivables
2,6162,6062,8642,9423,5963,753
Inventory
1,3211,3711,7491,9612,2141,305
Prepaid Expenses
-13.5512.513.2532.1116.77
Other Current Assets
239.62224.12217.18230.06336.93416.22
Total Current Assets
5,7355,7176,1496,7207,3856,806
Property, Plant & Equipment
2,9122,9533,1493,2423,3222,901
Long-Term Investments
178.36178.84235.58247.62244.03272.82
Goodwill
635.6635.6675.2692.54716.05716.05
Other Intangible Assets
258.83267.14298.45331.11352.73313.68
Long-Term Accounts Receivable
5.215.2126.3946.3794.1115.01
Long-Term Deferred Tax Assets
227.35223.41222.17129.29140.56108.16
Long-Term Deferred Charges
389.67393.54386.75402.6327.29311.53
Other Long-Term Assets
25.0218.0222.7723.1477.6862.51
Total Assets
10,36710,39211,16511,83512,66011,607
Accounts Payable
430.32449.97678.15713.45884.77605
Accrued Expenses
9.75268.52299.23184.08444.37519.36
Short-Term Debt
15.1314.8516.2423.18231.47293.79
Current Portion of Long-Term Debt
164.44116.65150.25167.67380.77100.02
Current Portion of Leases
-36.7545.2525.8855.0745.86
Current Income Taxes Payable
46.6510.2719.420.619.8215.12
Current Unearned Revenue
43.9752.0363.9776.27208.03137.56
Other Current Liabilities
509.99332.6348.67353.7463.6341.56
Total Current Liabilities
1,2201,2821,6211,5652,6782,058
Long-Term Debt
239.38260.59529.171,2571,3451,458
Long-Term Leases
97.08102.25111.1659.4278.1267.07
Long-Term Unearned Revenue
60.3262.0365.5662.5662.0467.55
Long-Term Deferred Tax Liabilities
29.9831.2839.5223.233.813.95
Total Liabilities
1,6471,7382,3672,9674,1973,655
Common Stock
3,0043,0043,0043,0043,0043,004
Additional Paid-In Capital
589.89589.89589.89589.49589.49589.49
Retained Earnings
5,0374,9715,0435,1124,6954,199
Comprehensive Income & Other
-51.55-48.796.834.750.86-19.98
Total Common Equity
8,5808,5178,6448,7108,2907,773
Minority Interest
140.59137.68154.66157.7172.87179.49
Shareholders' Equity
8,7208,6548,7998,8688,4637,952
Total Liabilities & Equity
10,36710,39211,16511,83512,66011,607
Total Debt
516.04531.1852.071,5332,0911,965
Net Cash (Debt)
1,042971.06454.1240.24-884.45-648.87
Net Cash Growth
109.01%113.83%1028.45%---
Net Cash Per Share
0.540.530.210.01-0.30-0.22
Filing Date Shares Outstanding
3,0043,0043,0043,0043,0043,004
Total Common Shares Outstanding
3,0043,0043,0043,0043,0043,004
Working Capital
4,5154,4354,5285,1554,7074,748
Book Value Per Share
2.862.832.882.902.762.59
Tangible Book Value
7,6857,6147,6707,6867,2216,743
Tangible Book Value Per Share
2.562.532.552.562.402.24
Buildings
-2,0001,9861,9881,7301,651
Machinery
-2,5522,5442,5142,1551,852
Construction In Progress
-130.89104.1954.11461.01232.93